scholarly journals The current state of chemotherapy for the treatment of gastrointestinal stromal tumors with different genotypes

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Yingying Xu ◽  
Wenqing Hu ◽  
Keyuan Xiao ◽  
Feng Wang ◽  
Wenxian Guan ◽  
...  
2017 ◽  
Vol 50 (3) ◽  
pp. 548-555
Author(s):  
Neil R. Sharma ◽  
Harishankar Gopakumar ◽  
Scott Harrison ◽  
Natalie Ehmke ◽  
Christina Zelt

2001 ◽  
Vol 120 (5) ◽  
pp. A401-A401 ◽  
Author(s):  
D EFRON ◽  
K LILLEMOE ◽  
J CAMERON ◽  
S TIERNEY ◽  
S ABRAHAM ◽  
...  

2018 ◽  
pp. 3-14

Gastrointestinal stromal tumors (GIST) are the most common mesenchymal tumors of the digestive tract (1%). These tumors express the CD 117 in 95% of cases. The stomach is the preferential localization (70%). Diagnosis is difficult and sometimes late. Progress of imaging has greatly improved the management and the prognosis. Computed tomography (CT) is the gold standard for diagnosis, staging, and treatment follow-up. The increasing recognition of GIST’s histopathology and the prolonged survival revealed some suggestive imaging aspects. Key words: gastro-intestinal stromal tumors; computed tomography; diagnosis


Sign in / Sign up

Export Citation Format

Share Document